Could a lab-made protein slow Alzheimer's? new trial begins.
NCT ID NCT06489015
First seen Apr 22, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This early-stage trial tests a lab-made version of a natural blood protein (rHSA) in 30 people with mild to moderate Alzheimer's. Participants receive one of three doses to check safety and any effect on memory and thinking. The goal is to see if this protein can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Medical College & Affiliated Hospital Of Jiujiang University
Jiujiang, Jiangxi, 332000, China
-
Luoyang Third People's Hospital
Luoyang, Henan, 471002, China
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200000, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450000, China
-
Wuhan Union Hospital of China
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.